Table 6. Summary of anti-aggregation agents for the treatment of Alzheimer's disease.

Name	Targets	Effects	Ref
Apomorphine	Prevents Aβ aggregation	Reduces cellular toxicity	299
Hormone melatonin	Inhibits Aβ aggregation	Reverts amyloid deposition	300
Cannabinoid HU-210	Blocks microglial activation	Prevents Aβ-promoted inflammation	296
Tannic Acid	Binds Aβ fibrils	Inhibits Aβ aggregation and cytotoxicity	301
LJW0F2	Polysaccharide that blocks Aβ fibril formation	Reduces neurotoxicity	302
EGb761	Inhibits Aβ aggregation	Reduces neurotoxicity	303
Isoliquiritigenin	Inhibits Aβ aggregation	Reduces neurotoxicity	304
Protocatechuic acid	Inhibits Aβ aggregation	Reduces neurotoxicity	304
Atractylenolide III	Inhibits Aβ aggregation	Reduces neurotoxicity	304
Chlorogenic acid	Inhibits Aβ aggregation	Reduces neurotoxicity	304
Euphorbiafactor L3	Inhibits Aβ aggregation	Reduces neurotoxicity	304
Euphorbiafactor L2	Inhibits Aβ aggregation	Reduces neurotoxicity	304
Ganoderic acid D	Inhibits Aβ aggregation	Reduces neurotoxicity	304
Ganoderic acid DM	Inhibits Aβ aggregation	Reduces neurotoxicity	304
Substituted Bisphenol A Derivatives	Inhibit Aβ aggregation	Inhibit neurotoxicity and increase cell viability	305